5 results match your criteria: "Center for Vaccine Development and Evaluation[Affiliation]"

We evaluated in a prospective study the immune response of naïve subjects to a single dose of inactivated Hepatitis A vaccine. Ninety-seven percent of the vaccinees sero-converted 1 month after vaccination and 93% were still positive 2 years later. All of the vaccinees had a strong booster response 2 years after the single dose.

View Article and Find Full Text PDF

We describe the first community-based evaluation of Shigella sonnei strain WRSS1, a live, oral candidate vaccine attenuated by a 212-bp deletion in the virG (or icsA) plasmid virulence gene. Three single-dose regimens of WRSS1 (5 x 10(3) CFU, 2 x 10(4) CFU, and 4 x 10(5) CFU) were tested with cohorts of 15 adult volunteers. The vaccine was generally well tolerated at the 10(3)- and 10(4)-CFU doses.

View Article and Find Full Text PDF

The study presented here was conducted to determine the genetic properties of noroviruses (NoVs) identified between 1999 and 2004 in army recruits with acute gastroenteritis. Partial sequence analysis of the RNA-dependent RNA polymerase gene revealed the presence of two major sub-genogroups, all of which were related to genogroup II of NoV. Serological analysis using recombinant antigens confirmed this observation.

View Article and Find Full Text PDF

Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus.

J Infect Dis

October 2004

Center for Vaccine Development and Evaluation, Israel Defense Force, and Department of Epidemiology and Preventive Medicine, Tel Aviv University, Ramat Aviv, Israel.

Background: During the winter of 2002-2003, the Israeli health authorities launched a campaign to vaccinate first responders against smallpox.

Methods: In an open study, 159 healthy, preimmunized adults, 24-52 years old, who participated in the campaign were vaccinated with the Lister strain of vaccinia virus by the multipuncture technique. The safety, immunogenicity, and reactogenicity of the vaccine were assessed.

View Article and Find Full Text PDF

An outbreak of pertussis among young Israeli soldiers.

Epidemiol Infect

December 2003

Center for Vaccine Development and Evaluation, Medical Corps, Israel Defense Force, M.P. 02149, Israel.

In winter 2001, an outbreak of pertussis involving an estimated 75 people occurred among soldiers serving in an infantry regiment of the Israeli Defense Forces (IDF). Nasopharyngeal swabs were obtained from patients and contacts for culture and PCR. Serum samples were obtained and assayed by ELISA for the presence of IgA, IgM and IgG antibodies to a lysate antigen of Bordetella pertussis.

View Article and Find Full Text PDF